Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Advanced Automation Researcher, R&D Platform Technology & Sciences at GlaxoSmithKline
Dr. Jaedeok Yoo joined GSK in 2014 and has been focusing on applications of 3DP in pharmaceutical R&D operations. His 3DP journey started at MIT in the early 90’s where he developed and used an inkjet printing based 3DP process to fabricate advanced ceramic materials with compositional gradient. He explored and demonstrated a wide range of pharmaceutical and biomedical applications of 3DP while working for Therics, Inc., a venture backed company that licensed the technology from MIT. In 2003, he co-founded Aprecia Pharmaceuticals and headed its research and engineering efforts to develop a high-speed, additive manufacturing process suitable for cGMP operation. His work resulted in the first ever FDA approval of a 3D printed pharmaceutical product, SPRITAM™, now manufactured and marketed by Aprecia. He is a co-inventor of many US and international patents on additive manufacturing of pharmaceutical and medical products. Prior to his graduate work at MIT, he studied Metallurgical Engineering and Materials Science at Carnegie Mellon University. He holds MBA from Wharton School at University of Pennsylvania.